Your browser doesn't support javascript.
loading
Phase I trial of bortezomib during maintenance phase after high dose melphalan and autologous stem cell transplantation in patients with multiple myeloma.
Abidi, Muneer H; Gul, Zartash; Abrams, Judith; Ayash, Lois; Deol, Abhinav; Ventimiglia, Marie; Lum, Lawrence; Mellon-Reppen, Stephanie; Al-Kadhimi, Zaid; Ratanatharathorn, Voravit; Zonder, Jeffrey; Uberti, Joseph.
Affiliation
  • Abidi MH; Department of Bone Marrow Transplantation, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA. abidim@karmanos.org
J Chemother ; 24(3): 167-72, 2012 Jun.
Article in En | MEDLINE | ID: mdl-22759762
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Boronic Acids / Stem Cell Transplantation / Maintenance Chemotherapy / Melphalan / Multiple Myeloma Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Chemother Journal subject: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Year: 2012 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Boronic Acids / Stem Cell Transplantation / Maintenance Chemotherapy / Melphalan / Multiple Myeloma Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Chemother Journal subject: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Year: 2012 Document type: Article Affiliation country: United States Country of publication: United kingdom